Skip to content

IMVT IMMUNOVANT INC

Follow

COM (common), issuer CIK 1764013

Filings received so far for Q3 2026: 5 13F filers report a position in IMVT shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Stout Jay Sofficer (Chief Technology Officer)2026-10-07-1,596 S$32.06Form 4
Stout Jay Sofficer (Chief Technology Officer)2026-10-07-2,213 S$32.06Form 4
Van Tuyl Christopherofficer (Chief Legal Officer)2026-10-07-1,327 S$32.06Form 4
Gloria Melanieofficer (Chief Operating Officer)2026-10-07-2,241 S$32.06Form 4

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Two Seas Capital LPin group Two Seas Capital LP4,612,692$156M6.21%+1,464,18713F-HRTimelineGroup
Farther Finance Advisors, LLC2,475$83.6K<0.01%+313F-HRTimeline
GAMMA Investing LLC1,224$41.3K<0.01%+47613F-HRTimeline
MassMutual Private Wealth & Trust, FSB93$3.14K<0.01%-9113F-HRTimeline
Trust Co21$709<0.01%013F-HRTimeline

Events

  • Stout Jay S sold 3,809 IMVT shares on 2026-10-07, Form 4 filed 2026-10-09. 0001702969-26-000012

    Accepted , ingested
  • Van Tuyl Christopher sold 1,327 IMVT shares on 2026-10-07, Form 4 filed 2026-10-09. 0001779707-26-000009

    Accepted , ingested
  • Gloria Melanie sold 2,241 IMVT shares on 2026-10-07, Form 4 filed 2026-10-09. 0001764013-26-000112

    Accepted , ingested